Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2000 participants.

Also called NCT06767774

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 2,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06767774
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06767774. Randomized; no masking; primary purpose prevention. Start 2025-04-25 (actual); primary completion 2029-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus
Condition
ASCVD
Condition
Diabetes
Condition
Statin
Intervention (Drug)
Combination therapy
Intervention (Drug)
High intensity statin monotherapy
Lead sponsor
Korea University Anam Hospital (class: other)
Collaborator
Daewon Pharmaceutical Co., Ltd. (class: industry)
Collaborator
Samjin Pharmaceutical Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct06767774
Content hash
d20e1a7a3d5a80981ea7c28520d971a26964ef88b1be31bddd9c57c3592e766c